文献速递营养与食品安全免疫规划

用志贺毒素2免疫妊娠母牛可诱导高水平特异性初乳抗体和乳铁蛋白,能中和大肠杆菌O157:H7的致病性

Immunization of pregnant cows with Shiga toxin-2 induces high levels of specific colostral antibodies and lactoferrin able to neutralize E. coli O157:H7 pathogenicity.
PubMed 文献 · Vaccine · 2018-02-23

本研究从经肌肉注射灭活志贺毒素2(Stx2)免疫的妊娠母牛获取超免疫初乳(HC),纯化初乳IgG并测定抗Stx2抗体和牛乳铁蛋白(bLF)水平,在HCT-8细胞、人结肠和鼠结肠袢及断奶小鼠模型中评价其对大肠杆菌O157:H7感染和Stx2细胞毒性的保护作用,结果显示HC-IgG/bLF能中和Stx2毒性并在断奶小鼠中100%预防致死性攻击。

要点

  • 经Stx2免疫的妊娠母牛初乳纯化IgG(HC-IgG/bLF)含高滴度抗Stx2抗体和高水平bLF。
  • HC-IgG/bLF在体外和体内均能中和Stx2的细胞毒性作用。
  • HC-IgG/bLF在断奶小鼠模型中100%预防大肠杆菌O157:H7致死性攻击。

核心结论

  • 本研究提示HC-IgG/bLF对大肠杆菌O157:H7感染具有保护作用,其有益效应可能源于特异性抗Stx2中和抗体与高水平bLF的共同作用。
  • 作者认为这些结果使HC-IgG/bLF可考虑作为营养保健品工具,与均衡支持性饮食联合用于预防溶血性尿毒综合征(HUS),但在作出治疗和临床应用推荐前仍需进一步研究。

研究设计与样本

  • 超免疫初乳(HC)取自经肌肉注射灭活Stx2免疫的母牛,对照母牛注射赋形剂。
  • 初乳IgG经亲和层析纯化,用ELISA测定HC及相应IgG(HC-IgG/bLF)中抗Stx2特异性IgG抗体和牛乳铁蛋白(bLF)水平。
  • 在HCT-8细胞中分析HC-IgG/bLF对Stx2细胞毒性及大肠杆菌O157:H7与其Stx2阴性突变体黏附的保护作用。
  • 在人结肠袢和大鼠结肠袢中研究HC-IgG/bLF对大肠杆菌O157:H7的预防作用。
  • 在断奶小鼠模型中评价对致死剂量大肠杆菌O157:H7攻击的保护作用。

主要发现

  • HC-IgG/bLF显示高抗Stx2滴度和高bLF水平,能在体外和体内中和Stx2的细胞毒性作用。
  • HC-IgG/bLF避免了大肠杆菌O157:H7在人结肠中引起的水吸收抑制。
  • HC-IgG/bLF在大鼠结肠袢中避免了大肠杆菌O157:H7和大肠杆菌O157:H7Δstx2的致病性。
  • HC-IgG/bLF在断奶小鼠模型中100%预防了大肠杆菌O157:H7引起的致死性。

临床怎么用

  • 作者认为HC-IgG/bLF可考虑作为营养保健品工具,与均衡支持性饮食联合用于预防HUS。
  • 作者指出在作出治疗和临床应用推荐前仍需进一步研究。

局限性

  • 原文指出在作出治疗和临床应用推荐前仍需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

E. coli O157:H7 is a foodborne pathogen responsible for bloody diarrhea, hemorrhagic colitis and hemolytic uremic syndrome (HUS). The objective of the present work was to evaluate the ability of colostral IgG obtained from Stx2-immunized cows to prevent against E. coli O157:H7 infection and Stx2 cytotoxicity. Hyperimmune colostrum (HC) was obtained from cows intramuscularly immunized with inactivated Stx2 or vehicle for controls. Colostral IgG was purified by affinity chromatography. Specific IgG antibodies against Stx2 and bovine lactoferrin (bLF) levels in HC and the corresponding IgG (HC-IgG/bLF) were determined by ELISA. The protective effects of HC-IgG/bLF against Stx2 cytotoxicity and adhesion of E. coli O157:H7 and its Stx2-negative mutant were analyzed in HCT-8 cells. HC-IgG/bLF prevention against E. coli O157:H7 was studied in human colon and rat colon loops. Protection against a lethal dose of E. coli O157:H7 was evaluated in a weaned mice model. HC-IgG/bLF showed high anti-Stx2 titers and high bLF levels that were able to neutralize the cytotoxic effects of Stx2 in vitro and in vivo. Furthermore, HC-IgG/bLF avoided the inhibition of water absorption induced by E. coli O157:H7 in human colon and also the pathogenicity of E. coli O157:H7 and E. coli O157:H7Δstx2 in rat colon loops. Finally, HC-IgG/bLF prevented in a 100% the lethality caused by E. coli O157:H7 in a weaned mice model. Our study suggests that HC-IgG/bLF have protective effects against E. coli O157:H7 infection. These beneficial effects may be due to specific anti-Stx2 neutralizing antibodies in combination with high bLF levels. These results allow us to consider HC-IgG/bLF as a nutraceutical tool which could be used in combination with balanced supportive diets to prevent HUS. However further studies are required before recommendations can be made for therapeutic and clinical applications.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Albanese A, Sacerdoti F, Seyahian EA, et al. Immunization of pregnant cows with Shiga toxin-2 induces high levels of specific colostral antibodies and lactoferrin able to neutralize E. coli O157:H7 pathogenicity. Vaccine. 2018. PMID: 29483033. doi:10.1016/j.vaccine.2018.02.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。